Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial). (Q33378384)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial). |
scientific article |
Statements
1 reference
Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial). (English)
1 reference
Eric Boersma
1 reference
Patrick W Serruys
1 reference
Joachim H Ix
1 reference
Michael G Shlipak
1 reference
Bernard J Gersh
1 reference
Nestor Mercado
1 reference
Mimi Guarneri
1 reference
Paul S Teirstein
1 reference
Jasper J Brugts
1 reference
Simon R Dixon
1 reference
William W O'Neill
1 reference
9 August 2008
1 reference
1 reference
102
1 reference
1151-1155
1 reference
Identifiers
1 reference
1 reference